Skip to main content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

East Carolina Cardiovascular Symposium 2020: Updates in Cardiovascular Medicine: Conference Topics 10 am - 12 pm

October 14, 2020

Conference Brochure

                                                                                                                                       

Updates in Atherosclerotic Cardiovascular Disease

1.

Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions.

Khera R, Valero-Elizondo J, Nasir K.

J Am Heart Assoc. 2020 Sep 13:e017793. doi: 10.1161/JAHA.120.017793. Online ahead of print.

PMID: 32924728

2.

Lipid Lowering Drug Therapy.

Chhetry M, Jialal I.

2020 Sep 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.

PMID: 31082172 Free Books & Documents. Review.

3.

Study of lipoprotein(a) and its impact on atherosclerotic cardiovascular disease: Design and rationale of the Mass General Brigham Lp(a) Registry.

Berman AN, Biery DW, Ginder C, Hulme OL, Marcusa D, Leiva O, Wu WY, Singh A, Divakaran S, Hainer J, Turchin A, Januzzi JL, Natarajan P, Cannon CP, Di Carli MF, Bhatt DL, Blankstein R.

Clin Cardiol. 2020 Sep 6. doi: 10.1002/clc.23456. Online ahead of print.

PMID: 32893370

4.

Predicting Risk of Atherosclerotic Cardiovascular Disease Using Pooled Cohort Equations in Older Adults With Frailty, Multimorbidity, and Competing Risks.

Nguyen QD, Odden MC, Peralta CA, Kim DH.

J Am Heart Assoc. 2020 Sep 15;9(18):e016003. doi: 10.1161/JAHA.119.016003. Epub 2020 Sep 2.

PMID: 32875939

5.

Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review.

Daniel CM, Davila L, Makris UE, Mayo H, Caplan L, Davis L, Solow EB.

ACR Open Rheumatol. 2020 Sep;2(9):525-532. doi: 10.1002/acr2.11170. Epub 2020 Sep 1.

PMID: 32869533

6.

Projections of incident atherosclerotic cardiovascular disease and incident type 2 diabetes across evolving statin treatment guidelines and recommendations: A modelling study.

Engeda JC, Lhachimi SK, Rosamond WD, Lund JL, Keyserling TC, Safford MM, Colantonio LD, Muntner P, Avery CL.

PLoS Med. 2020 Aug 26;17(8):e1003280. doi: 10.1371/journal.pmed.1003280. eCollection 2020 Aug.

PMID: 32845900 Free PMC article.

7.

Nutritional Therapy for Asian Patients at Risk for Atherosclerotic Cardiovascular Disease.

Lim H, Kim J, Kim DY.

J Lipid Atheroscler. 2019 Sep;8(2):192-203. doi: 10.12997/jla.2019.8.2.192. Epub 2019 Sep 21.

PMID: 32821709 Free PMC article. Review.

8.

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.

Mahtta D, Ramsey DJ, Al Rifai M, Nasir K, Samad Z, Aguilar D, Jneid H, Ballantyne CM, Petersen LA, Virani SS.

JAMA Netw Open. 2020 Aug 3;3(8):e2011051. doi: 10.1001/jamanetworkopen.2020.11051.

PMID: 32816031 Free PMC article.

9.

Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can "Thrombin Pathway" Be a New Target for Therapy?

Kim HK, Tantry US, Gurbel PA, Jeong YH.

Korean Circ J. 2020 Sep;50(9):817-821. doi: 10.4070/kcj.2020.0287.

PMID: 32812410 Free PMC article. No abstract available.

10.

Lowering Low-Density Lipoprotein Cholesterol Concentration with Plant Stanol Esters to Reduce the Risk of Atherosclerotic Cardiovascular Disease Events at a Population Level: A Critical Discussion.

Gylling H, Strandberg TE, Kovanen PT, Simonen P.

Nutrients. 2020 Aug 6;12(8):2346. doi: 10.3390/nu12082346.

PMID: 32781511 Free PMC article.

Updates in Arrhythmias & Device Therapy

1.

Ventricular fibrillation in congenitally corrected transposition of great arteries treated with pacing: a case report.

Zhang L, Liu H, Wan Q, Han X.

Eur Heart J Case Rep. 2019 Oct 30;3(4):1-6. doi: 10.1093/ehjcr/ytz199. eCollection 2019 Dec.

PMID: 32123788 Free PMC article.

2.

Takotsubo syndrome and cardiac implantable electronic device therapy.

El-Battrawy I, Erath JW, Lang S, Ansari U, Behnes M, Gietzen T, Zhou X, Borggrefe M, Akin I.

Sci Rep. 2019 Nov 12;9(1):16559. doi: 10.1038/s41598-019-52929-5.

PMID: 31719584 Free PMC article.

3.

Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients.

Zhou Y, Zhao S, Chen K, Hua W, Su Y, Chen S, Liang Z, Xu W, Zhang S.

BMC Cardiovasc Disord. 2019 Oct 21;19(1):230. doi: 10.1186/s12872-019-1218-9.

PMID: 31638918 Free PMC article.

4.

A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice.

Vijapurapu R, Kozor R, Hughes DA, Woolfson P, Jovanovic A, Deegan P, Rusk R, Figtree GA, Tchan M, Whalley D, Kotecha D, Leyva F, Moon J, Geberhiwot T, Steeds RP.

Trials. 2019 May 31;20(1):314. doi: 10.1186/s13063-019-3425-1.

PMID: 31151481 Free PMC article. Clinical Trial.

5.

Patent foramen ovale closure versus medical therapy for cryptogenic stroke: An updated systematic review and meta-analysis.

Goel S, Patel S, Zakin E, Pasam RT, Gotesman J, Malik BA, Ayzenberg S, Frankel R, Shani J.

Indian Heart J. 2019 Nov-Dec;71(6):446-453. doi: 10.1016/j.ihj.2019.10.002. Epub 2019 Oct 22.

PMID: 32248916

6.

Where is the missing piece of the puzzle? Failed device therapy in patients with left ventricular assist device.

Haseeb S, Gul EE.

Turk Kardiyol Dern Ars. 2018 Dec;46(8):740-741. doi: 10.5543/tkda.2018.61365.

PMID: 30516545 No abstract available.

7.

Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.

Bettin M, Larbig R, Rath B, Fischer A, Frommeyer G, Reinke F, Köbe J, Eckardt L.

JACC Clin Electrophysiol. 2017 Dec 26;3(13):1499-1506. doi: 10.1016/j.jacep.2017.08.017. Epub 2017 Nov 6.

PMID: 29759830

8.

Evaluation of the Impact of a Chronic Total Coronary Occlusion on Ventricular Arrhythmias and Long-Term Mortality in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator (the eCTOpy-in-ICD Study).

van Dongen IM, Yilmaz D, Elias J, Claessen BEPM, Delewi R, Knops RE, Wilde AAM, van Erven L, Schalij MJ, Henriques JPS.

J Am Heart Assoc. 2018 May 2;7(10):e008609. doi: 10.1161/JAHA.118.008609.

PMID: 29720502 Free PMC article.

9.

A clinical approach to arrhythmias revisited in 2018 : From ECG over noninvasive and invasive electrophysiology to advanced imaging.

Jordaens L.

Neth Heart J. 2018 Apr;26(4):182-189. doi: 10.1007/s12471-018-1089-1.

PMID: 29450695 Free PMC article. Review.

10.

Gender differences and demographics and type of cardiac device over a 10-year period.

Aktoz M, Uçar MF, Y─▒lmaztepe MA, Taylan G, Altay S.

Niger J Clin Pract. 2018 Jan;21(1):27-32. doi: 10.4103/1119-3077.224797.

PMID: 29411719

Updates in Cardiovascular Pharmacotherapeutics

1.

Risk factors associated with potential cardiovascular and cerebrovascular adverse events in elderly individuals assisted at secondary level.

Oliveira HSB, Michels AC, Nahime M, Caetano LM, Corradi MLG.

Rev Assoc Med Bras (1992). 2020 Aug;66(8):1087-1092. doi: 10.1590/1806-9282.66.8.1087.

PMID: 32935803

2.

Efficacy and safety of PCSK9 monoclonal antibodies: an evidence-based review and update.

Kaddoura R, Orabi B, Salam AM.

J Drug Assess. 2020 Aug 11;9(1):129-144. doi: 10.1080/21556660.2020.1801452.

PMID: 32939318 Free PMC article. Review.

3.

Carfilzomib induced cardiotoxicity in a multiple myeloma patient.

Méndez-Toro A, Díaz-Brochero C, Acosta-Gutiérrez E.

Cardiooncology. 2020 Sep 7;6:17. doi: 10.1186/s40959-020-00074-8. eCollection 2020.

PMID: 32944287 Free PMC article.

4.

Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies.

Samidurai A, Das A.

Int J Mol Sci. 2020 Sep 16;21(18):E6790. doi: 10.3390/ijms21186790.

PMID: 32947927 Review.

5.

Artificial Intelligence, Machine Learning, and Cardiovascular Disease.

Mathur P, Srivastava S, Xu X, Mehta JL.

Clin Med Insights Cardiol. 2020 Sep 9;14:1179546820927404. doi: 10.1177/1179546820927404. eCollection 2020.

PMID: 32952403 Free PMC article. Review.

6.

Lipid Lowering Drug Therapy.

Chhetry M, Jialal I.

2020 Sep 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020 Jan–.

PMID: 31082172 Free Books & Documents. Review.

7.

Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis.

Plein S, Erhayiem B, Fent G, Horton S, Dumitru RB, Andrews J, Greenwood JP, Emery P, Hensor EM, Baxter P, Pavitt S, Buch MH.

Ann Rheum Dis. 2020 Aug 28:annrheumdis-2020-217653. doi: 10.1136/annrheumdis-2020-217653. Online ahead of print.

PMID: 32859608

8.

Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can "Thrombin Pathway" Be a New Target for Therapy?

Kim HK, Tantry US, Gurbel PA, Jeong YH.

Korean Circ J. 2020 Sep;50(9):817-821. doi: 10.4070/kcj.2020.0287.

PMID: 32812410 Free PMC article. No abstract available.

9.

A Novel Hybrid Drug Delivery System for Treatment of Aortic Aneurysms.

Yoshimura K, Aoki H, Teruyama C, Iijima M, Tsutsumi H, Kuroda S, Hamano K.

Int J Mol Sci. 2020 Aug 2;21(15):5538. doi: 10.3390/ijms21155538.

PMID: 32748844 Free PMC article.

10.

Optimization of Lipid-Lowering Therapy for High Cardiovascular Risk Patients Through Electronic Medical Record Reporting and Pharmacist Evaluation.

Chen K, Canfield S, Blackwell J, Houmes S, Jones S, Lindsley J.

J Manag Care Spec Pharm. 2020 Aug;26(8):1010-1016. doi: 10.18553/jmcp.2020.26.8.1010.

PMID: 32715962